Free Trial

Stifel Nicolaus' Rating of City Therapeutics on 11/10/2026

On November 10, 2026, Stifel Nicolaus updated its outlook on City Therapeutics (NASDAQ:CTY) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Stifel Nicolaus

DateCompanyAction
11/13/2026
GH Research PLC stock logo
GHRS
GH Research
Set Price Target
11/13/2026
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
Lower Price Target
11/13/2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
Lower Price Target
11/13/2026
Heartflow, Inc. stock logo
HTFL
Heartflow
Boost Price Target
11/13/2026
ITG
ITG
Lower Price Target
11/13/2026
Proficient Auto Logistics, Inc. stock logo
PAL
Proficient Auto Logistics
Lower Price Target
More Ratings From Stifel Nicolaus